The cardiovascular, coagulation and haematological effects of Tiger Snake (Notechis scutatus) venom

Anaesthesia and Intensive Care

Volumn 26, Issue 5, 1998, Pages 529-535

  Tibballs, J ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Envenomation: Tiger Snake, Notechis scutatus, cardiovascular, coagulation, haematological

Indexed keywords

FIBRINOGEN; SNAKE VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSISTED VENTILATION; BLOOD CLOTTING; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DOG; DOSE RESPONSE; FIBRINOGEN BLOOD LEVEL; FORWARD HEART FAILURE; HEART MUSCLE ISCHEMIA; HEMATOLOGY; HYPOTENSION; LEUKOPENIA; LUNG ARTERY PRESSURE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; PULMONARY HYPERTENSION; THROMBOCYTOPENIA;

EID: 0031790591     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x9802600510     Document Type: Article

References (29)

1. Sutherland SK. Australian Animal Toxins: The Creatures, their Toxins and Care of the Poisoned Patient. Oxford University Press, Melbourne 1983.
2. Sutherland SK. Deaths from snake bite in Australia, 1981-1991. Med J Aust 1992; 157:740-746.
3. Sutherland SK, Leonard RL. Snakebite deaths in Australia 1992-1994 and a management update. Med J Aust 1995; 163: 616-618.
4. Martin CJ. On some effects upon the blood produced by the injection of the venom of the Australian Black Snake (Pseudechis porphyriacus). J Physiol 1894; XV:380-401.
5. Feldberg W, Kellaway CH. The circulatory and pulmonary effects of the venom of the Australian Copperhead (Denisonia superba). Aust J Exp Biol Med Sci 1937; 15:81-95.
6. Tibballs J, Sutherland S, Kerr S. Studies on Australian snake venoms. Part I: The haemodynamic effects of Brown Snake (Pseudonaja) species in the dog. Anaesth Intensive Care 1989; 17:466-469.
7. Broad AJ, Sutherland SK, Coulter AR. The lethality in mice of dangerous Australian and other snake venoms. Toxicon 1979; 17:664-667.
8. Altman DG. Practical statistics for medical research. Chapman & Hall, London; 1991.
9. Morrison JJ, Pearn JH, Coulter AR, Tanner C, Charles NT. The quantity of venom injected by elapid snakes. Toxicon 1983; suppl 3:309-312.
10. Lee CY. Chemistry and pharmacology of polypeptide toxins in snake venoms. Ann Rev Pharmacol 1972; 12:265-286.
11. Lee CY, Lee SY. Cardiovascular effects of snake venoms. In: Lee CY, ed. Snake Venoms, Handbook of Experimental Pharmacology, vol 52, Springer-Verlag, Berlin 1979;547-590.
12. Kellaway CH, LeMessurier DH. The vaso-depressant action of the venom of the Australian Copperhead (Denisonia superba). Aust J Exp Biol Med Sci 1936; 14:57-76.
13. Feldberg W, Kellaway CH. Circulatory effects of the venom of the Indian Cobra (Naia naia) in cats. Aust J Exp Biol Med Sci 1937; 15:159-172.
14. Feldberg W, Kellaway CH. Circulatory effects of the venom of the Indian Cobra (Naia naia) in dogs. Aust J Exp Biol Med Sci 1937; 15:441-460.
15. Bhanganada K, Perry JF. Cardiovascular effects of Cobra venom. JAMA 1963; 183:257-259.
16. Francis B, John TR, Seebart C, Kaiser II. New toxins from the venom of the common Tiger Snake (Notechis scutatus scutatus). Toxicon 1991; 29:85-96.
17. Fairley NH. Criteria for determining the efficacy of ligature in snake bite. Med J Aust 1929; I:377-394.
18. Tibballs J. Cardiovascular, coagulation and haematological effects of Brown and Tiger snake venoms. MD Thesis. The University of Melbourne, 1998.
19. Fry BG. Structure-function properties of venom components from Australian elapids. Centre for Drug Design and Development, University of Queensland, St Lucia, Old (undated).
20. 2 from the venom of the Australian Tiger Snake (Notechis scutatus scutatus). Arch Biochem Biophys 1995; 318:481-488.
21. Barnes PJ, Henson PM. Platelet-activating factor. In: Crystal RG, West JB, Barnes PJ, Cherniack NS, Webel ER, eds. The Lung, Scientific Foundations. Raven Press Ltd, New York 1991; 49-59.
22. Camussi G, Aglietta M, Malavasi F et al. The release of platelet-activating factor from human endothelial cells in culture. J Immunol 1983; 131: 2397-2403.
23. Chignard M, LeCouedic JP, Vargaftig BB, Benveniste J. Platelet-activating factor (PAF-accther) secretion from platelets; effect of aggregating agents. Br J Haematol 1980; 46: 455-464.
24. 2. A review. Fed Proc 1987; 46:133-138.
25. Piper PJ, Stewart AG. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists. Br J Pharmacol 1987; 90:771-783.
26. Tans G, Govers-Reimslag JWP, van Rijn JLML, Rosing J. Purification and properties of a prothrombin activator from the venom of Notechis scutatus scutatus. J Biol Chem 1985; 260:9366-9370.
27. Marshall LR, Herrmann RP. Coagulant and anticoagulant actions of Australian snake venoms. Thrombos Haemostas 1983; 50:707-711.
28. Marshall LR, Herrmann RP. Australian snake venoms and their in vitro effect on human platelets. Thrombos Res 1989; 54:269-275.
29. Lewis PF. Some toxicity thresholds for the clinical effects of common tiger snake (Notechis scutatus) envenomation in the dog. Aust Vet J 1994; 71: 133-135.